Yarlagadda S. Babu

2014

In 2014, Yarlagadda S. Babu earned a total compensation of $2.1M as Senior Vice President of at BioCryst Pharmaceuticals, a 90% increase compared to previous year.

Compensation breakdown

Bonus$54,911
Non-Equity Incentive Plan$100,243
Option Awards$974,413
Salary$405,854
Stock Awards$583,200
Other$13,000
Total$2,131,621

Babu received $974.4K in option awards, accounting for 46% of the total pay in 2014.

Babu also received $54.9K in bonus, $100.2K in non-equity incentive plan, $405.9K in salary, $583.2K in stock awards and $13K in other compensation.

Rankings

In 2014, Yarlagadda S. Babu's compensation ranked 4,262nd out of 13,032 executives tracked by ExecPay. In other words, Babu earned more than 67.3% of executives.

ClassificationRankingPercentile
All
4,262
out of 13,032
67th
Division
Manufacturing
1,507
out of 4,966
70th
Major group
Chemicals And Allied Products
496
out of 1,686
71st
Industry group
Drugs
383
out of 1,365
72nd
Industry
Biological Products, Except Diagnostic Substances
65
out of 236
73rd
Source: SEC filing on April 12, 2017.

Babu's colleagues

We found four more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2014.

2014

Jon Stonehouse

BioCryst Pharmaceuticals

Chief Executive Officer

2014

William Sheridan

BioCryst Pharmaceuticals

Chief Medical Officer

2014

Thomas Staab

BioCryst Pharmaceuticals

Chief Financial Officer

2014

Alane Barnes

BioCryst Pharmaceuticals

General Counsel

News

You may also like